Lupin launches first generic of Pred Forte Ophthalmic Suspension in the US

Prednisolone Acetate Ophthalmic Suspension USP, 1% is a generic equivalent of Pred Forte Ophthalmic Suspension, 1% of AbbVie, Inc. and is indicated for the treatment of steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of

the globe. Pred Forte had estimated annual sales of USD 198 million in the U.S. (IQVIA MAT August 2024).